This study treated the HCT116 cell line with Staurosporine (STS, a non-selective protein kinase inhibitor), Vorinostat (SAHA, an HDAC inhibitor), and Tunicamycin (Tuni, an N-glycosylation inhibitor) to investigate the phosphoproteome, N-glycoproteome, and acetylproteome.